Deadline For Abstract Submissions: July 1, 2012
The following guidelines apply for submission of presentations. All presenters must also register for the 22nd Annual Meeting and Symposium. Click the topics below for further details.
- Paper Presentations offer an opportunity to briefly present research findings or data on clinical experiences. These presentations are organized into concurrent 60-minute sessions with each abstract presentation 10 minutes in duration followed by an additional 5 minute question/answer period.
- Posters are displayed throughout the conference with the author(s) hosting informal sessions about their work.
- Workshops are 90-minute sessions which emphasize an interactive learning process around a specific topic. The emphasis will be on skills development and small group discussion as opposed to dissemination of information in a lecture format.
Read all information carefully. Abstracts that do not comply with these instructions will not be accepted for review.
E-mail submissions must be sent as a Word document attachment, typed in 12-point font, single-spaced with 1” margins. No tables, figures or images may be included in the abstract.
The title must not exceed 15 words and should appear in title case. Excluding the title and author information, submissions are limited to a maximum of 250 words.
Indicate the authors’ names, degrees, institutional affiliation, city and state.
Begin the body of the abstract on a new line. Abbreviations within the body should be kept to a minimum.
The abstract should not contain references.
Indicate source of funding (i.e. NIH Institute, Foundation, Health Care Company, Pharmaceutical Company, etc.)
Submissions must be received via email to Isabel@aaap.org
or submitted online no later than June 1, 2012.
Trade names will not be permitted.
Disclosure of who funded the research to be presented is required.
All presenters must be registered for the conference and pay the full registration fee.
Slides are expected from workshop and paper presenters, must be submitted to program staff no later than October 1, 2012 as they will be provided to all participants in the meeting packets.
Accepted abstracts will be printed in the Final Conference Program.
Presenters will be required to sign a disclosure form acknowledging potential conflicts of interests.
Presenters may not use any conference presentation to market products or services.
Acceptance letters will be mailed or e-mailed by August 1, 2012.
SUBMISSIONS MUST CONFORM TO THE FOLLOWING PRESENTATION FORMATS:
Paper and Poster Presentations
Submissions must contain data (either quantitative or qualitative) and report research results.
Submissions should be organized under the following headings:
- Background: Describe the importance of the study and state the objective(s).
- Methods: Provide a description of the methods used: study design, setting, population, measures, and analytic procedures.
- Results: Describe the results to support the conclusions.
- Conclusions: State the implications of the findings for clinical practice, research, education, or policy.
- Funding: (Indicate source of funding, i.e., NIH Institute, Foundation, Health Care Company, Pharmaceutical, etc.)
- The same paper may not be submitted for both a paper presentation and poster.
- Papers that have been published or accepted for publication either in article or abstract form prior to the abstract submission deadline will not be eligible for review.
- Papers under review at the time of the submission deadline but not yet accepted for publication, even if appearing before the meeting, are eligible for presentation.
- During the review process, the Review Committee may recommend the author convert a paper submission to a poster. Authors should indicate their presentation preference (poster or paper) on the abstract submission form.
Workshops should be interactive, with an emphasis on audience participation in discussions, skill-building exercises, etc. Participation in workshops should impact attendee’s teaching, clinical, policy and/or administrative work.
- Learning Objective(s): Provide the objectives of the workshop. Learning objectives are a tool to assist in identifying the specific steps that will be taken to address the gap between an identified need and the "best practice." This is what the participant should be able to do as a result of the CME activity.
- Brief Summary of Workshop: Describe the workshop in 250 words or less.
- Contents and Methods: Describe the identified objectives to be accomplished. List the methods, strategies, materials and resources to be used by the workshop facilitator. Please specify how you will meet the goal to make this an interactive session. Note: No more than half of the workshop time (45 minutes or less) will be spent on presentation and the remaining time will be dedicated for discussion and interactive exercises with the audience.
- Additional Presenters: List name, degree, and institutional affiliation for any additional presenters who will be involved in the workshop.
- Funding: (Indicate source of funding, i.e., NIH Institute, Grant Number, Foundation, Health Care Company, Pharmaceutical, etc.)
The American Academy of Addiction Psychiatry encourages abstract submissions for paper, posters, and workshops presentations by racial and ethnic minorities and women, as well as other underrepresented groups, are strongly encouraged.
Disclaimer: AAAP is a private, non-profit organization which reserves the right to remove any presentation from its' public forums if questions arise that may compromise the reputation of AAAP. Presentations may be withdrawn by AAAP for various reasons which include, but are not limited to: 1) concerns about pharmaceutical or private corporate influence on or funding for work to be presented, 2) questions regarding the research methodology, analysis and conclusions, or 3) evidence that data was altered or misrepresented.
For further information email email@example.com or call (401) 524-3076.